ChartMill assigns a Buy % Consensus number of 43% to TTOO. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-30 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-04-29 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2023-07-13 | Alliance Global Partners | Maintains | Neutral -> Neutral |
| 2023-01-24 | Alliance Global Partners | Maintains | Neutral |
| 2022-10-14 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-07-07 | BTIG | Downgrade | Buy -> Neutral |
| 2022-07-07 | Alliance Global Partners | Downgrade | Buy -> Neutral |
| 2022-02-18 | Alliance Global Partners | Upgrade | Neutral -> Buy |
6 analysts have analysed TTOO and the average price target is 5.1 USD. This implies a price increase of 3705.97% is expected in the next year compared to the current price of 0.134.
The consensus rating for T2 BIOSYSTEMS INC (TTOO) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.